Cleared Traditional

K112766 - SNORKEL

K112766 is an FDA 510(k) clearance for SNORKEL, manufactured by Fellmar Company. The device is a Class 2 Dental device with product code LQZ cleared through the Traditional 510(k) pathway after a 256-day FDA review.

K112766 · Fellmar Company · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2012
Decision
256d
Days
Class 2
Risk

K112766 is an FDA 510(k) clearance for the SNORKEL. Classified as Device, Jaw Repositioning (product code LQZ), Class II - Special Controls.

Submitted by Fellmar Company (Monrovia, US). The FDA issued a Cleared decision on June 4, 2012 after a review of 256 days - an extended review cycle.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.5570 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.

View all Fellmar Company devices

FDA 510(k) Submission Details - K112766

510(k) Number K112766 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 22, 2011
Decision Date June 04, 2012
Days to Decision 256 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
129d slower than avg
Panel avg: 127d · This submission: 256d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LQZ Device Classification - Class 2, Special Controls

Product Code LQZ Device, Jaw Repositioning
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.5570
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.